ArticleRisk management and healthcare policy2023

Drug Pricing of Domestic Anti-PD-L1 Antibody Adebrelimab: Cost-Effectiveness Analysis of the First-Line ES-SCLC Treatment in China.

Dongchu Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.